Comparison of two serotype 1 MDV isolates

A M Miles1, A S Anderson, E L Bernberg

  • 1Delaware Agricultural Experiment Station, Department of Animal and Food Sciences, College of Agricultural Sciences, University of Delaware, Newark 19717-1303, USA.

Acta Virologica
|March 4, 2000
PubMed

Insights

Marek's disease virus (MDV) serotype 1 isolates were compared. The T. King (TK) isolate caused more damage, but was later found to be contaminated with chicken infectious anemia virus (CIAV).

Area of Science:

  • Poultry Virology
  • Immunology
  • Animal Pathology

Background:

  • Marek's disease virus (MDV) causes significant economic losses in the poultry industry.
  • Understanding the pathogenicity of different MDV serotypes and isolates is crucial for effective disease control.
  • Previous comparisons of MDV isolates have not always accounted for potential co-infections.

Purpose of the Study:

  • To compare the in vivo pathogenicity of two Marek's disease virus (MDV) serotype 1 isolates: RB1B and T. King (TK).
  • To assess the impact of these isolates on host factors including body and organ weights, mortality, and lesion development.
  • To identify potential confounding factors in MDV pathogenicity studies.

Main Methods:

  • In vivo comparison of RB1B and T. King (TK) serotype 1 MDV isolates in chickens.
  • Monitoring of body and organ weights, mortality rates, and gross pathological lesions.
  • Subsequent analysis of the TK inoculum for the presence of other viral agents.

Main Results:

  • The TK isolate demonstrated more efficient early infection establishment compared to the RB1B isolate.
  • Greater damage to the bursa of Fabricius and thymus was observed with the TK inoculum.
  • Post-study analysis revealed chicken infectious anemia virus (CIAV) contamination in the TK inoculum.

Conclusions:

  • The observed pathogenicity profile of the TK isolate was influenced by co-infection with CIAV.
  • Pathogenicity comparisons of MDV isolates require careful consideration of potential viral contamination.
  • Future studies should ensure the purity of viral stocks for accurate pathogenicity assessments.

Related Concept Videos